Related Experiment Video
Updated: Aug 7, 2025
13:32
High Content Screening in Neurodegenerative Diseases
Published on: January 6, 2012
17.6K
Advances in Neurodegenerative Diseases.
Jeroen Van Schependom1,2, Miguel D'haeseleer1,3,4
1Center for Neurosciences, NEUR and AIMS Research Groups, Vrije Universiteit Brussel (VUB), Laarbeeklaan 103, 1090 Brussel, Belgium.
Journal of Clinical Medicine
|March 11, 2023
Summary
Neurological disorders cause significant global disability, impacting 15% of people worldwide. Research is crucial to understand and combat these debilitating conditions.
Area of Science:
- Neurology
- Neuroscience
- Public Health
Background:
- Neurological disorders represent a major global health challenge, leading to extensive physical and cognitive impairment.
- Approximately 15% of the global population is affected by these conditions, highlighting their widespread impact.
Discussion:
- The increasing prevalence necessitates urgent research into the underlying mechanisms of neurological diseases.
- Understanding the diverse range of neurological conditions is key to developing effective interventions.
- The socioeconomic burden of neurological disorders requires comprehensive public health strategies.
Key Insights:
- Neurological conditions are the primary cause of disability globally.
- A significant portion of the world's population experiences the effects of these disorders.
- Further investigation into neurological disease is critical for improving patient outcomes.
Outlook:
- Future research should focus on early diagnosis and targeted therapies for neurological disorders.
- Developing innovative treatments and preventative measures is essential.
- Enhancing global health infrastructure to support neurological care is a priority.
Related Concept Videos
01:26Alzheimer's Disease: Overview
575
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
575
01:15Parkinson's Disease: Overview
634
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
634
01:22Alzheimer's Disease: Treatment
233
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
233
01:30Dementia
150
Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual....
The progression of dementia is generally gradual....
150
01:24Parkinson's Disease: Treatment
323
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
323
01:37Neural Regulation
39.6K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
39.6K